Regulation of Tau Pathology by the Microglial Fractalkine Receptor

Bhaskar, Kiran, Konerth, Megan, Kokiko-Cochran, Olga N., Cardona, Astrid, Ransohoff, Richard M., Lamb, Bruce T.·2010·Neuron
DOI 10.1016/j.neuron.2010.08.023

Cited by (642)

Items 301–400 of 642

  1. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death
    Masami Suzuki, Nazira El‐Hage, Shiping Zou, Yun-Kyung Hahn, Mary E. Sorrell, Jamie Sturgill, Daniel H. Conrad, Pamela E. Knapp, Kurt F. Hauser · 2011 · Molecular Neurodegeneration
  2. Treponema denticola Induces Alzheimer-Like Tau Hyperphosphorylation by Activating Hippocampal Neuroinflammation in Mice
    Z. Tang, Xingqun Cheng, X. Su, Linrui Wu, Q. Cai, Hongle Wu · 2022 · Journal of Dental Research
  3. P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases
    A. S. Zelentsova, Alexey V. Deykin, Vladislav O. Soldatov, Anastasia A. Ulezko, Alina Y. Borisova, Veronika S. Belyaeva, M. Yu. Skorkina, Plamena R. Angelova · 2022 · eNeuro
  4. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
    Goran Šimić, Ena Španić, Lea Langer Horvat, Patrick R. Hof · 2019 · Progress in molecular biology and translational science
  5. Critical Molecular and Cellular Contributors to Tau Pathology
    Liqing Song, Evan A. Wells, Anne Skaja Robinson · 2021 · Biomedicines
  6. The mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: The effect on inflammatory gene expression
    Grzegorz Arkadiusz Czapski, Magdalena Gąssowska-Dobrowolska, Anna Wilkaniec, Małgorzata Chalimoniuk, Joanna Benigna Strosznajder, Agata Adamczyk · 2016 · Neurochemistry International
  7. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
    Todd Eliot Golde, Wolfgang J. Streit, Paramita Chakrabarty · 2013 · Alzheimer s Research & Therapy
  8. Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease
    Chloe McKee, Madison Hoffos, Haley A. Vecchiarelli, Marie‐Ève Tremblay · 2023 · Frontiers in Pharmacology
  9. Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
    Nanjundaiah, Shwetha, Chidambaram, Hariharakrishnan, Chandrashekar, Madhura, Chinnathambi, Subashchandrabose · 2021 · Cellular and Molecular Neurobiology
  10. Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy
    Neil S. Donison, Jacqueline Palik, Kathryn Volkening, Michael Joseph Strong · 2025 · Molecular Neurodegeneration
  11. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
    Finneran, Dylan J., Morgan, Dave, Gordon, Marcia N., Nash, Kevin R. · 2019 · Journal of Neuroimmune Pharmacology
  12. Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease
    Alessio Crestini, Francesca Santilli, Stefano Martellucci, Elena Carbone, Maurizio Sorice, Paola Piscopo, Vincenzo Mattei · 2021 · Journal of Alzheimer s Disease
  13. Complex role of chemokine mediators in animal models of Alzheimer's Disease
    Elodie Martin, Cécile Delarasse · 2018 · Biomedical Journal
  14. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease
    Giulia Bivona, Matilda Iemmolo, Giulio Ghersi · 2023 · International Journal of Molecular Sciences
  15. Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases
    Nicole M. Desforges, Michaeline L. Hebron, Norah Khaled Algarzae, Irina Lonskaya, Charbel Moussa · 2012 · International Journal of Alzheimer s Disease
  16. The Fine Balance of Chemokines During Disease: Trafficking, Inflammation, and Homeostasis
    Sandra M. Cardona, Jenny A. Garcia, Astrid E. Cardona · 2013 · Methods in molecular biology
  17. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology
    Nicole M. Maphis, Shanya Jiang, Jessica Binder, Carrie Wright, Banu Gopalan, Bruce T. Lamb, Kiran Bhaskar · 2017 · Frontiers in Molecular Neuroscience
  18. Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees
    Melissa K. Edler, Chet C. Sherwood, Richard S. Meindl, Emily L. Munger, William Donald Hopkins, John J. Ely, JOSEPH M. ERWIN, Daniel P. Perl, Elliott Jay Mufson, Patrick R. Hof et al. · 2018 · The Journal of Comparative Neurology
  19. Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection
    Jayasri Das Sarma, Amy C Burrows, Patricia A. Rayman, Mihyun Hwang, Soumya Kundu, Nikhil Sharma, Cornelia C. Bergmann, Ganes C. Sen · 2020 · PLoS Pathogens
  20. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration
    Alejandra Martínez-Maldonado, Miguel Ángel Ontiveros‐Torres, Charles R. Harrington, José Francisco Montiel-Sosa, Raúl García-Tapia Prandiz, Alma Patricia Bocanegra-López, Andrew Michael Sorsby-Vargas, Marely Bravo-Muñoz, Benjamí­n Florán, Ignacio Villanueva‐Fierro et al. · 2021 · Journal of Alzheimer s Disease
  21. How Many Cell Types Does It Take to Wire a Brain?
    Richard M. Ransohoff, Beth Stevens · 2011 · Science
  22. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
    Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, Helen Chen, Bettina E. Kalisch · 2024 · Current Issues in Molecular Biology
  23. The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
    Mandana AmeliMojarad, Melika AmeliMojarad, Xiaonan Cui · 2024 · Frontiers in Aging Neuroscience
  24. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases
    Matilda Iemmolo, Giulio Ghersi, Giulia Bivona · 2023 · International Journal of Molecular Sciences
  25. Vascularized Brain Assembloids With Enhanced Cellular Complexity Provide Insights Into the Cellular Deficits of Tauopathy
    Xiaohuan Sun, Simeon Kofman, Victor C. Ogbolu, Celeste M M. Karch, Larisa Ibric, Liang Qiang · 2023 · Stem Cells
  26. Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology
    Francesca Michela Pramotton, Sarah Spitz, Roger Dale Kamm · 2024 · Advanced Science
  27. Metabolic Endotoxemia: From the Gut to Neurodegeneration
    Mateusz Chmielarz, Beata Sobieszczańska, Kamila Środa-Pomianek · 2024 · International Journal of Molecular Sciences
  28. R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease
    Isabel Carreras, Ann Carolyn McKee, Ji‐Kyung Choi, Nurgül Aytan, Neil W. Kowall, Bruce G. Jenkins, Alpaslan Dedeoglu · 2013 · Brain Research
  29. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
    Mak Adam Daulatzai · 2016 · Europe PMC (PubMed Central)
  30. The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
    Yao Shen, Liyin Qian, Hu Luo, Xiaofang Li, Yuer Ruan, Runyue Fan, Zizhen Si, Yun-Peng Chen, Longhui Li, Yu Liu · 2022 · Brain Sciences
  31. Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomography
    Mak, Elijah, Nicastro, Nicolas, Malpetti, Maura, Savulich, George, Surendranathan, Ajenthan, Holland, Negin, Passamonti, Luca, Jones, P Simon, Carter, Stephen F., Su, Li et al. · 2021 · Neurobiology of Aging
  32. Traumatic brain injury in hTau model mice: enhanced acute macrophage response and altered long-term recovery
    Kokiko-Cochran, Olga N., Saber, Maha, Puntambekar, Shweta, Bemiller, Shane M., Katsumoto, Atsuko, Lee, Yu-Shang, Bhaskar, Kiran, Ransohoff, Richard M., Lamb, Bruce T. · 2018 · Journal of Neurotrauma
  33. Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer’s Disease
    Shanya Jiang, Kiran Bhaskar · 2017 · Journal of Alzheimer s Disease
  34. Hydrolyzed Chicken Meat Extract Attenuates Neuroinflammation and Cognitive Impairment in Middle-Aged Mouse by Regulating M1/M2 Microglial Polarization
    Liyang Ni, Fen Zhuge, Song Yang, Lingyan Ma, Aqian Zheng, Yufeng Zhao, Luting Hu, Zhengwei Fu, Yinhua Ni · 2021 · Journal of Agricultural and Food Chemistry
  35. Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
    Hai Yang, Jin‐Ping Li, Xiaoxiong Li, Linqiu Ma, Mingliang Hou, Huadong Zhou, Rui Zhou · 2022 · Frontiers in Molecular Neuroscience
  36. Impaired burrowing is the most prominent behavioral deficit of aging htau mice
    Philippine C. Geiszler, Matthew Richard Barron, Marie‐Christine Pardon · 2016 · Neuroscience
  37. Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity
    Dworzak, Jenny, Renvoisé, Benoît, Habchi, Johnny, Yates, Emma V., Combadière, Christophe, Knowles, Tuomas P., Dobson, Christopher M., Blackstone, Craig, Paulsen, Ole, Murphy, Philip M. · 2015 · PLOS ONE
  38. Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
    Jin-Hee Park, Jeong-Woo Hwang, Hyunju Lee, Geum Mi Jang, Yoo Joo Jeong, Joonho Cho, Jinsoo Seo, Hyang‐Sook Hoe · 2023 · Frontiers in Immunology
  39. Tau-Targeted Therapeutic Strategies: Mechanistic Targets, Clinical Pipelines, and Analysis of Failures
    Xiaoxia Shen, Huan Li, Beiyu Zhang, Yunan Li, Zheying Zhu · 2025 · Cells
  40. Microglial Cx3cr1knockout reduces prion disease incubation time in mice
    Julia Grizenkova, Shaheen Akhtar, Sebastian Brandner, John Collinge, Sarah E. Lloyd · 2014 · BMC Neuroscience
  41. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.
    Mak Adam Daulatzai · 2016 · Europe PMC (PubMed Central) · Retracted
  42. Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia
    Agnieszka Kulczyńska‐Przybik, Agnieszka Słowik, Piotr Mroczko, Bartłomiej Borawski, Magdalena Groblewska, Renata Borawska, Barbara Mroczko · 2020 · Current Alzheimer Research
  43. New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer’s Disease
    Na Li, Mingru Deng, Gonghui Hu, Nan Li, Haicheng Yuan, Yu Zhou · 2022 · Biomolecules
  44. The involvement of microglia in Alzheimer's disease: a new dog in the fight
    Moore, Zachery, Taylor, Juliet M, Crack, Peter J · 2019 · British Journal of Pharmacology
  45. A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1+ microglia
    Jun Tang, Hongping Miao, Bing‐Hua Jiang, Qianwei Chen, Liang Tan, Yihao Tao, Jianbo Zhang, Fabao Gao, Hua Feng, Gang Zhu et al. · 2017 · Neuropharmacology
  46. IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer’s disease mouse model
    Niklas Lonnemann, Shirin Hosseini, Melanie Ohm, Robert Geffers, Karsten Hiller, Charles Anthony Dinarello, Martin Körte · 2022 · eLife
  47. Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
    Harald Lund, Melanie Pieber, Robert Adam Harris · 2017 · Frontiers in Aging Neuroscience
  48. The Microglial Response to Neurodegenerative Disease
    Wilbur M. Song, Marco Colonna · 2018 · Advances in immunology
  49. Microglial activation and neuroinflammation in acute and chronic cognitive deficits in sepsis
    Paul Denver, Colm M. Cunningham · 2024 · Neuropharmacology
  50. Pathophysiology of Trans-Synaptic Adhesion Molecules: Implications for Epilepsy
    Adam Gorlewicz, Leszek Kaczmarek · 2018 · Frontiers in Cell and Developmental Biology
  51. Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
    Francis J. Herman, Sherry J. Simkovic, Giulio Maria Pasinetti · 2019 · British Journal of Pharmacology
  52. Neuroinflammation in frontotemporal lobar degeneration revealed by 11 C‐PBR28 PET
    Min-Jeong Kim, Meghan McGwier, Kimberly J. Jenko, Joseph Snow, Cheryl L. Morse, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, William Charles Kreisl · 2019 · Annals of Clinical and Translational Neurology
  53. Exosomes: A missing link between chronic systemic inflammation and Alzheimer’s disease?
    Mehmet Ozansoy, Houda Mikati, Halil Aziz Velioğlu, Burak Yuluğ · 2023 · Biomedicine & Pharmacotherapy
  54. Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer’s disease
    Xiao Li, Dengfeng Zhang, Rui Bi, Liwen Tan, Xiaogang Chen, Min Xu, Yong‐Gang Yao · 2023 · Alzheimer s Research & Therapy
  55. Fyn depletion ameliorates tauP301L-induced neuropathology
    Guanghao Liu, Kimberly L. Fiock, Yona Levites, Todd Eliot Golde, Marco M. Hefti, Gloria S. Lee · 2020 · Acta Neuropathologica Communications
  56. RETRACTION OF: The Influence of 5-Lipoxygenase on Alzheimer’s Disease-Related Tau Pathology: In Vivo and In Vitro Evidence
    Jin Chu, Jian-Guo Li, Carolina Ceballos‐Diaz, Todd Eliot Golde, Domenico Praticò · 2013 · Biological Psychiatry · Retracted
  57. Chronic pain in Alzheimer's disease: Endocannabinoid system
    Henry L. Blanton, P. Hemachandra Reddy, Khalid Benamar · 2022 · Experimental Neurology
  58. Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
    Stopschinski, Barbara E., Weideman, Rick A., McMahan, Danni, Jacob, David A., Little, Bertis B., Chiang, Hsueh-Sheng, Saez Calveras, Nil, Stuve, Olaf · 2023 · Therapeutic Advances in Neurological Disorders
  59. Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
    Rahma Hassan-Abdi, Alexandre Brenet, Mohamed Bennis, Constantin Yanicostas, Nadia Soussi‐Yanicostas · 2019 · Frontiers in Neuroscience
  60. CX3CL1 Action on Microglia Protects from Diet-Induced Obesity by Restoring POMC Neuronal Excitability and Melanocortin System Activity Impaired by High-Fat Diet Feeding
    Jineta Banerjee, Mauricio D. Dorfman, Rachael D. Fasnacht, John D. Douglass, Alice C. Wyse‐Jackson, Andrés Barría, Joshua P. Thaler · 2022 · International Journal of Molecular Sciences
  61. Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive Function
    Angélique Sadlon, Petros Takousis, Barbara Ankli, Panagiotis Alexopoulos, Robert Perneczky, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Annals of Neurology
  62. S100A8 ‐enriched microglia populate the brain of tau‐seeded and accelerated aging mice
    Roxane Gruel, Baukje Bijnens, Johanna Van Den Daele, Sofie Thys, Roland Willems, Dirk Wuyts, Debby Van Dam, Peter Verstraelen, Rosanne Verboven, Jana Roels et al. · 2024 · Aging Cell
  63. Propranolol diminished severity of rat EAE by enhancing immunoregulatory/protective properties of spinal cord microglia
    Ivan Pilipović, Zorica Stojić-Vukanić, Ivana Prijić, Nebojsa I. Jasnic, Gordana Leposavić · 2019 · Neurobiology of Disease
  64. Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy
    Bemiller, Shane M., Maphis, Nicole M., Formica, Shane V., Wilson, Gina N., Miller, Crystal M., Xu, Guixiang, Kokiko-Cochran, Olga N., Kim, Ki-Wook, Jung, Steffen, Cannon, Judy L. et al. · 2018 · Journal of Neuroinflammation
  65. Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
    Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, Md. Abubakar, Puneet Kumar, Thakur Gurjeet Singh, Randhir Singh · 2024 · Phytotherapy Research
  66. A systematic review of large animal models of combined traumatic brain injury and hemorrhagic shock
    Andrew R. Mayer, Andrew B. Dodd, Meghan S. Vermillion, David D. Stephenson, Irshad H. Chaudry, Denis E. Bragin, Andrew P. Gigliotti, Rebecca J. Dodd, Benjamin C Wasserott, Priyank Shukla et al. · 2019 · Neuroscience & Biobehavioral Reviews
  67. Imaging of neuroinflammation in adult Niemann-Pick type C disease
    Mark Walterfang, Maria Angelique Di Biase, Vanessa Cropley, Andrew Mark Scott, Graeme Joseph O'Keefe, Dennis Velakoulis, Kunthi Pathmaraj, Uwe Ackermann, Christos Pantelis · 2020 · Neurology
  68. Microglia in motor neuron disease: Signaling evidence from last 10 years
    Min‐Jia Wang, Kang Lu, Yao‐Zheng Wang, Bi‐Ru Yang, Chun Zhang, Yu‐Feng Lu, Liang Kang · 2022 · Developmental Neurobiology
  69. Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation
    Bernardino Ossola, Chao Zhao, Alastair Compston, Stefano Pluchino, Robin J.M. Franklin, Maria Grazia Spillantini · 2015 · Glia
  70. Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease
    Mak Adam Daulatzai · 2016 · Neurotoxicity Research
  71. The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy
    Hadijat M. Makinde, Talia B. Just, Carla Marie Cuda, Harris Perlman, Steven J. Schwulst · 2017 · Shock
  72. The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
    Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, Maha A.E. Ahmed, Noha F. Abdelkader · 2025 · European Journal of Pharmacology
  73. Microglia in Alzheimer’s Disease
    Patrick Süß, Johannes C. M. Schlachetzki · 2020 · Current Alzheimer Research
  74. p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
    Juan Ramón Perea, Marta Bolós, Raquel Cuadros, Esther García, Vega García‐Escudero, Félix Hernández, Róisín M. McManus, Michael Thomas Heneka, Jesús Ávila · 2022 · Molecular Neurobiology
  75. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD
    Lisanne Korn, Anna M. Speicher, Christina B. Schroeter, Lukas Gola, Thilo Kaehne, Alexander Engler, Paul Disse, Juncal Fernández‐Orth, Júlia Csatári, Michael Naumann et al. · 2022 · Redox Biology
  76. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
    Sophie Layé, Charlotte Madore, Isabelle St‐Amour, Jean-Christophe Delpech, Corinne Joffre, Agnès Nadjar, Frédéric Calon · 2015 · Nutrition and Aging
  77. Alterations of functional circuitry in aging brain and the impact of mutated APP expression
    Elaine L. Bearer, Brett C. Manifold-Wheeler, Christopher S. Medina, Aaron Gonzales, Frances L. Chaves, Russell E. Jacobs · 2018 · Neurobiology of Aging
  78. Microglia: Friends or Foes in Glaucoma? A Developmental Perspective
    Iqbal Ahmad, Murali Subramani · 2022 · Stem Cells Translational Medicine
  79. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1I249/M280-expressing retina
    Kaira A. Church, Derek Rodriguez, Andrew S. Mendiola, Difernando Vanegas, Irene L. Gutiérrez, Ian M. Tamayo, Abdul Amadu, Priscila Velazquez, Sandra M. Cardona, Stefka Gyoneva et al. · 2023 · Frontiers in Immunology
  80. P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
    Qiang Huang, Jun Ying, Wen Yu, Yao Dong, Hao Xiong, Yiping Zhang, Jie Liu, Xifeng Wang, Fuzhou Hua · 2023 · Molecular Neurobiology
  81. Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
    Szymon Kotarba, Marta Kozłowska, Małgorzata Scios, Kamil Saramowicz, Julia Barczuk, Zuzanna Granek, Natalia Siwecka, Wojciech Wiese, Michał Golberg, Grzegorz Galita et al. · 2024 · International Journal of Molecular Sciences
  82. The persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics
    Leon G. Coleman, Fulton T. Crews, Ryan P. Vetreno · 2021 · International review of neurobiology
  83. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
    Tuancheng Feng, Huan Du, Cha Yang, Ya Wang, Fenghua Hu · 2024 · Acta Neuropathologica
  84. Research Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
    Yixuan Yang, Lina Qiu · 2024 · Brain Sciences
  85. A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy
    Megan Torvell, David W. Hampton, Peter Connick, Alasdair M. J. MacLullich, Colm M. Cunningham, Siddharthan Chandran · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  86. Intermittent Fasting: A Promising Approach for Preventing Vascular Dementia
    Yoon, Gwangho, Song, Juhyun · 2019 · Journal of Lipid and Atherosclerosis
  87. Exploring the link between dystrophic microglia and the spread of Alzheimer's neuropathology
    Ryan K. Shahidehpour, Peter T. Nelson, Yuriko Katsumata, Adam D. Bachstetter · 2024 · Brain
  88. Role of chemokines in aging and age-related diseases
    Jitendra Kumar Chaudhary, Ajay Kumar Danga, Anita Kumari, Akshay Bhardwaj, Pramod C. Rath · 2024 · Mechanisms of Ageing and Development
  89. Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
    Inbal Lahiani-Cohen, Olga Touloumi, Roza Lagoudaki, Nikolaos Grigoriadis, Hanna Rosenmann · 2020 · Frontiers in Cell and Developmental Biology
  90. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
    Matthew R. Barron, Jane E. Gartlon, Lee A. Dawson, Peter J. Atkinson, Marie‐Christine Pardon · 2020 · Frontiers in Immunology
  91. Metformin alleviates prolonged isoflurane inhalation induced cognitive decline via reducing neuroinflammation in adult mice
    Liangyu Peng, Shuai Liu, Jiyan Xu, Wenjia Xie, Xin Fang, Tianjiao Xia, Xiaoping Gu · 2022 · International Immunopharmacology
  92. The innate immune response in tauopathies
    Alexis M. Johnson, John R. Lukens · 2023 · European Journal of Immunology
  93. Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
    Pei Ou-Yang, Zhiyu Cai, Zhong-Hao Zhang · 2023 · Aging and Disease
  94. Neuron–microglia interactions in neuroinflammation
    Tetsuya Mizuno · 2015 · Clinical and Experimental Neuroimmunology
  95. Tauopathies: Mechanisms and Therapeutic Strategies
    Chen‐Chen Tan, Xiao-Yan Zhang, Lan Tan, Jin‐Tai Yu · 2017 · Journal of Alzheimer s Disease
  96. Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
    Sahar Balkhi, Anna Di Spirito, Alessandro Delli Poggi, Lorenzo Mortara · 2025 · Cells
  97. Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons
    Jessica Binder, Praveen N. Chander, Vojo P. Deretic, Jason Porter Weick, Kiran Bhaskar · 2020 · PLoS ONE
  98. Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
    Xiaobo Yang, Hengbing Zu, Yongfei Zhao, Kai Yao · 2022 · Frontiers in Aging Neuroscience
  99. Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice
    Namiko Kawamura, Goro Katsuura, Nobuko Yamada-Goto, Riho Nakama, Yuki Kambe, Atsuro Miyata, Tomoyuki Furuyashiki, Shuh Narumiya, Yoshihiro Ogawa, Akio Inui · 2022 · Scientific Reports
  100. Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives
    Dominika Przewodowska, Weronika Zofia Marzec, Natalia Madetko‐Alster · 2021 · Frontiers in Molecular Neuroscience